Follow the 그린생명과학 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 그린생명과학 has logged 31 insider filings. Market capitalisation: €42.4bn. The latest transaction was disclosed on 22 June 2026 (Other). Among the most active insiders: 건덕상사. The full history is openly available.
30
Insider Decl.
n/a
Thresholds
n/a
19 ops.
Buy Volume
n/a
n/a
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,949 of 28,065 companies
19.0
score / 100
Value
23
Quality
15
FCF yld-1.8%
Earn yld0.2%
EV/EBITDA45.9x
ROE·
Gross mgn6.1%
Net mgn0.3%
Debt/EBITDA6.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Green Life Science is a company in the health and pharmaceutical sector listed on the XKRX market. It focuses on developing innovative solutions in the life sciences field.